Monthly Archives: October 2017

Bill Burns nominated for election to Molecular Partners’ Board of Directors as Vice-Chairman with nomination to Chairman in 2018

By | Uncategorized | No Comments

The Board of Directors of Molecular Partners has nominated William (Bill) Burns, former CEO of Roche Pharmaceuticals, for election to the Board at an EGM on October 31, 2017, after which the Board of Directors plans to appoint him Vice-Chairman. At the EGM Patrick Amstutz, CEO of Molecular Partners, also stands for election to the Board.

Read More